Vault-13

TYNDALL CAPITAL PARTNERS L P

NEW YORK, NY · CIK 1219314 · 13F filing filed 2024-11-27

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$379.0k reported value -28.1% vs Q1 2024
1positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2024

This manager withheld holdings under SEC confidential treatment in both Q2 2024 and Q1 2024, so new and sold-out positions can't be determined.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CYCLERION THERAPEUTICS INC COM COM 164,777 $379.0k100.00% 100.00% UnchangedShares held: Q3 2023 147.7k, Q4 2023 164.4k, Q1 2024 164.8k, Q2 2024 164.8k